Literature DB >> 10913859

Identification of type 4 fimbriae in Actinobacillus pleuropneumoniae.

Y Zhang1, J M Tennent, A Ingham, G Beddome, C Prideaux, W P Michalski.   

Abstract

Type 4 fimbriae have been identified on the cell surface of Actinobacillus pleuropneumoniae by electron microscopy and N-terminal sequencing analysis. A. pleuropneumoniae type 4 fimbrial subunit protein, purified from cell cultures and from outer membrane preparations, reacted with polyclonal antibody raised against type 4 fimbriae of Moraxella bovis on Western blots. N-terminal sequence analysis of the purified 17 kDa type 4 fimbrial subunit protein, named ApfA, revealed the first 12 amino acids to be identical to those of other type 4 fimbrial subunit proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913859     DOI: 10.1111/j.1574-6968.2000.tb09199.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  11 in total

1.  Seventeen Sxy-dependent cyclic AMP receptor protein site-regulated genes are needed for natural transformation in Haemophilus influenzae.

Authors:  Sunita Sinha; Joshua C Mell; Rosemary J Redfield
Journal:  J Bacteriol       Date:  2012-07-20       Impact factor: 3.490

2.  Demonstration of Type IV pilus expression and a twitching phenotype by Haemophilus influenzae.

Authors:  Lauren O Bakaletz; Beth D Baker; Joseph A Jurcisek; Alistair Harrison; Laura A Novotny; James E Bookwalter; Rachna Mungur; Robert S Munson
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

3.  Yersinia pseudotuberculosis harbors a type IV pilus gene cluster that contributes to pathogenicity.

Authors:  François Collyn; Marie-Annick Léty; Shamila Nair; Vincent Escuyer; Amena Ben Younes; Michel Simonet; Michaël Marceau
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

4.  Functional characterization of AasP, a maturation protease autotransporter protein of Actinobacillus pleuropneumoniae.

Authors:  Tehmeena Ali; Neil J Oldfield; Karl G Wooldridge; David P Turner; Dlawer A A Ala'Aldeen
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

5.  Adherence of actinobacillus pleuropneumoniae serotype 1 to swine buccal epithelial cells involves fibronectin.

Authors:  Roberto Hamer-Barrera; Delfino Godínez; V Idalia Enríquez; Sergio Vaca-Pacheco; Rodrigo Martinez-Zúñiga; Patricia Talamás-Rohana; Francisco Suárez-Güemez; Mireya de la Garza
Journal:  Can J Vet Res       Date:  2004-01       Impact factor: 1.310

Review 6.  Virulence factors of Actinobacillus pleuropneumoniae involved in colonization, persistence and induction of lesions in its porcine host.

Authors:  Koen Chiers; Tine De Waele; Frank Pasmans; Richard Ducatelle; Freddy Haesebrouck
Journal:  Vet Res       Date:  2010-06-15       Impact factor: 3.683

7.  Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice.

Authors:  Meili Shao; Yong Wang; Chunlai Wang; Yang Guo; Yonggang Peng; Jiandong Liu; Guangxing Li; Huifang Liu; Siguo Liu
Journal:  Acta Vet Scand       Date:  2010-09-11       Impact factor: 1.695

8.  Branched-chain amino acids are required for the survival and virulence of Actinobacillus pleuropneumoniae in swine.

Authors:  Sargurunathan Subashchandrabose; Rhiannon M LeVeque; Trevor K Wagner; Roy N Kirkwood; Matti Kiupel; Martha H Mulks
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

9.  Host-pathogen interactions of Actinobacillus pleuropneumoniae with porcine lung and tracheal epithelial cells.

Authors:  Eliane Auger; Vincent Deslandes; Mahendrasingh Ramjeet; Irazù Contreras; John H E Nash; Josée Harel; Marcelo Gottschalk; Martin Olivier; Mario Jacques
Journal:  Infect Immun       Date:  2009-01-12       Impact factor: 3.441

10.  Host cell contact-induced transcription of the type IV fimbria gene cluster of Actinobacillus pleuropneumoniae.

Authors:  Bouke K H L Boekema; Jos P M Van Putten; Norbert Stockhofe-Zurwieden; Hilde E Smith
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.